Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells via p53-Induced Quiescence.

Garbern JC, Helman A, Sereda R, Sarikhani M, Ahmed A, Escalante GO, Ogurlu R, Kim SL, Zimmerman JF, Cho A, MacQueen L, Bezzerides VJ, Parker KK, Melton DA, Lee RT.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044205. [Epub ahead of print]

PMID:
31707831
2.

Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents.

DeWitt ES, Chandler SF, Hylind RJ, Beausejour Ladouceur V, Blume ED, VanderPluym C, Powell AJ, Fynn-Thompson F, Roberts AE, Sanders SP, Bezzerides V, Lakdawala NK, MacRae CA, Abrams DJ.

J Am Coll Cardiol. 2019 Jul 23;74(3):346-358. doi: 10.1016/j.jacc.2019.05.022.

PMID:
31319917
3.

Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart Tissue.

Park SJ, Zhang D, Qi Y, Li Y, Lee KY, Bezzerides VJ, Yang P, Xia S, Kim SL, Liu X, Lu F, Pasqualini FS, Campbell PH, Geva J, Roberts AE, Kleber AG, Abrams DJ, Pu WT, Parker KK.

Circulation. 2019 Jul 30;140(5):390-404. doi: 10.1161/CIRCULATIONAHA.119.039711. Epub 2019 Jul 17.

PMID:
31311300
4.

Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II.

Bezzerides VJ, Caballero A, Wang S, Ai Y, Hylind RJ, Lu F, Heims-Waldron DA, Chambers KD, Zhang D, Abrams DJ, Pu WT.

Circulation. 2019 Jul 30;140(5):405-419. doi: 10.1161/CIRCULATIONAHA.118.038514. Epub 2019 Jun 3.

PMID:
31155924
5.

Phenotypic Characterization of Individuals With Variants in Cardiovascular Genes in the Absence of a Primary Cardiovascular Indication for Testing.

Hylind RJ, Chandler SF, Beausejour Ladouceur V, Roberts AE, Bezzerides V, Christensen KD, Coggins M, Lakdawala NK, MacRae CA, Abrams DJ.

Circ Genom Precis Med. 2019 Mar;12(3):e002463. doi: 10.1161/CIRCGEN.119.002463. No abstract available.

PMID:
30919684
6.

Activin type II receptor signaling in cardiac aging and heart failure.

Roh JD, Hobson R, Chaudhari V, Quintero P, Yeri A, Benson M, Xiao C, Zlotoff D, Bezzerides V, Houstis N, Platt C, Damilano F, Lindman BR, Elmariah S, Biersmith M, Lee SJ, Seidman CE, Seidman JG, Gerszten RE, Lach-Trifilieff E, Glass DJ, Rosenzweig A.

Sci Transl Med. 2019 Mar 6;11(482). pii: eaau8680. doi: 10.1126/scitranslmed.aau8680.

PMID:
30842316
7.

The Real-World Utility of the LINQ Implantable Loop Recorder in Pediatric and Adult Congenital Heart Patients.

Bezzerides VJ, Walsh A, Martuscello M, Escudero CA, Gauvreau K, Lam G, Abrams DJ, Triedman JK, Alexander ME, Bevilacqua L, Mah DY.

JACC Clin Electrophysiol. 2019 Feb;5(2):245-251. doi: 10.1016/j.jacep.2018.09.016.

PMID:
30784698
8.

Differentiation of fasciculoventricular fibers from anteroseptal accessory pathways using the surface electrocardiogram.

O'Leary ET, Dewitt ES, Mah DY, Gauvreau K, Walsh EP, Bezzerides VJ.

Heart Rhythm. 2019 Jul;16(7):1072-1079. doi: 10.1016/j.hrthm.2019.02.011. Epub 2019 Feb 11.

PMID:
30763786
9.

Dual-Site Ventricular Pacing in Patients With Fontan Physiology and Heart Block: Does it Mitigate the Detrimental Effects of Single-Site Ventricular Pacing?

O'Leary ET, Gauvreau K, Alexander ME, Banka P, Bezzerides VJ, Fynn-Thompson F, Triedman JK, Walsh EP, Mah DY.

JACC Clin Electrophysiol. 2018 Oct;4(10):1289-1297. doi: 10.1016/j.jacep.2018.07.004. Epub 2018 Aug 29.

PMID:
30336874
10.

Channelopathy as a SUDEP Biomarker in Dravet Syndrome Patient-Derived Cardiac Myocytes.

Frasier CR, Zhang H, Offord J, Dang LT, Auerbach DS, Shi H, Chen C, Goldman AM, Eckhardt LL, Bezzerides VJ, Parent JM, Isom LL.

Stem Cell Reports. 2018 Sep 11;11(3):626-634. doi: 10.1016/j.stemcr.2018.07.012. Epub 2018 Aug 23.

11.

Utility of incomplete right bundle branch block as an isolated ECG finding in children undergoing initial cardiac evaluation.

Meziab O, Abrams DJ, Alexander ME, Bevilacqua L, Bezzerides V, Mah DY, Walsh EP, Triedman JK.

Congenit Heart Dis. 2018 May;13(3):419-427. doi: 10.1111/chd.12589. Epub 2018 Feb 12.

PMID:
29431296
12.

Genotype-phenotype-guided medical and surgical intervention in long QT syndrome.

Hylind RJ, Ladouceur VB, Fynn-Thompson F, Hourigan SE, Bezzerides VJ, Abrams DJ.

HeartRhythm Case Rep. 2017 Oct 28;4(1):14-17. doi: 10.1016/j.hrcr.2017.09.001. eCollection 2018 Jan. No abstract available.

13.

Low molecular weight heparin as an anticoagulation strategy for left-sided ablation procedures.

Hinsley K, Evans-Langhorst M, Porter C, Chandler S, VanderPluym C, Triedman J, Bezzerides VJ.

Congenit Heart Dis. 2018 Mar;13(2):222-225. doi: 10.1111/chd.12551. Epub 2017 Nov 27.

PMID:
29181868
14.

Mitochondrial Cardiomyopathy Caused by Elevated Reactive Oxygen Species and Impaired Cardiomyocyte Proliferation.

Zhang D, Li Y, Heims-Waldron D, Bezzerides V, Guatimosim S, Guo Y, Gu F, Zhou P, Lin Z, Ma Q, Liu J, Wang DZ, Pu WT.

Circ Res. 2018 Jan 5;122(1):74-87. doi: 10.1161/CIRCRESAHA.117.311349. Epub 2017 Oct 11.

15.

Cardiac Events During Competitive, Recreational, and Daily Activities in Children and Adolescents With Long QT Syndrome.

Chambers KD, Beausejour Ladouceur V, Alexander ME, Hylind RJ, Bevilacqua L, Mah DY, Bezzerides V, Triedman JK, Walsh EP, Abrams DJ.

J Am Heart Assoc. 2017 Sep 21;6(9). pii: e005445. doi: 10.1161/JAHA.116.005445.

16.

Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders.

Bezzerides VJ, Zhang A, Xiao L, Simonson B, Khedkar SA, Baba S, Ottaviano F, Lynch S, Hessler K, Rigby AC, Milan D, Das S, Rosenzweig A.

Sci Rep. 2017 Mar 23;7(1):346. doi: 10.1038/s41598-017-00413-3.

17.

Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Bezzerides VJ, Zhang D, Pu WT.

Circ J. 2016 Dec 22;81(1):12-21. doi: 10.1253/circj.CJ-16-1113. Epub 2016 Dec 3. Review.

18.

Pausing With the Gauze: Inhibition of Temporary Pacemakers by Radiofrequency Scan During Cardiac Surgery.

Williams MR, Atkinson DB, Bezzerides VJ, Yuki K, Franklin K, Casta A, Alexander ME.

Anesth Analg. 2016 Nov;123(5):1143-1148.

PMID:
27644061
19.

Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.

Lin Z, Guo H, Cao Y, Zohrabian S, Zhou P, Ma Q, VanDusen N, Guo Y, Zhang J, Stevens SM, Liang F, Quan Q, van Gorp PR, Li A, Dos Remedios C, He A, Bezzerides VJ, Pu WT.

Dev Cell. 2016 Nov 21;39(4):466-479. doi: 10.1016/j.devcel.2016.09.005. Epub 2016 Oct 6.

20.

CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury.

Bezzerides VJ, Platt C, Lerchenm├╝ller C, Paruchuri K, Oh NL, Xiao C, Cao Y, Mann N, Spiegelman BM, Rosenzweig A.

JCI Insight. 2016 Jun 16;1(9). pii: e85904.

21.

miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling.

Liu X, Xiao J, Zhu H, Wei X, Platt C, Damilano F, Xiao C, Bezzerides V, Bostr├Âm P, Che L, Zhang C, Spiegelman BM, Rosenzweig A.

Cell Metab. 2015 Apr 7;21(4):584-95. doi: 10.1016/j.cmet.2015.02.014.

22.

Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.

Ryall KA, Bezzerides VJ, Rosenzweig A, Saucerman JJ.

J Mol Cell Cardiol. 2014 Jul;72:74-84. doi: 10.1016/j.yjmcc.2014.02.013. Epub 2014 Mar 5.

23.

Saying yes to exercise and NO to cardiac injury.

Bezzerides V, Rosenzweig A.

Circ Res. 2011 Jun 10;108(12):1414-6. doi: 10.1161/CIRCRESAHA.111.247122. No abstract available.

24.

Rapid vesicular translocation and insertion of TRP channels.

Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE.

Nat Cell Biol. 2004 Aug;6(8):709-20. Epub 2004 Jul 18.

PMID:
15258588
25.

Mechanism of persistent protein kinase D1 translocation and activation.

Oancea E, Bezzerides VJ, Greka A, Clapham DE.

Dev Cell. 2003 Apr;4(4):561-74.

Supplemental Content

Loading ...
Support Center